Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefit-risk relationship.

Literature DB >> 31785258

The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefit-risk relationship.

Michael A Nauck¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2019 PMID： 31785258 DOI： 10.1016/j.metabol.2019.154031

Source DB: PubMed Journal: Metabolism ISSN： 0026-0495 Impact factor: 8.694

Keyword Cloud
Cited

× No keyword cloud information.

4 in total

Review 1. Incretin based therapy and pancreatic cancer: Realising the reality.

Authors: Varun Suryadevara; Ayan Roy; Jayaprakash Sahoo; Sadishkumar Kamalanathan; Dukhabandhu Naik; Pazhanivel Mohan; Raja Kalayarasan
Journal: World J Gastroenterol Date: 2022-07-07 Impact factor: 5.374

Review 2. GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.

Authors: Michael A Nauck; Daniel R Quast; Jakob Wefers; Juris J Meier
Journal: Mol Metab Date: 2020-10-14 Impact factor: 7.422

Review 3. The Impact of Novel Anti-Diabetic Medications on CV Outcomes: A New Therapeutic Horizon for Diabetic and Non-Diabetic Cardiac Patients.

Authors: Israel Mazin; Fernando Chernomordik; Paul Fefer; Shlomi Matetzky; Roy Beigel
Journal: J Clin Med Date: 2022-03-29 Impact factor: 4.241

4. Incretin-based therapies in 2021 - current status and perspectives for the future.

Authors: Manfredi Rizzo; Michael A Nauck; Christos S Mantzoros
Journal: Metabolism Date: 2021-07-29 Impact factor: 8.694

4 in total